Half of U.S. economic growth since WWII stems from innovation made possible by federally-funded research. More recently, federally funded studies by the National Institutes of Health (NIH) contributed to the science that underlies every one of the 210 new drugs approved between 2010 and 2016.
Yet, today, the United States is rapidly losing its competitive advantage in biomedical engineering & innovation. The U.S. now ranks 6th on the Global Innovation Index, down from 1st in 2007.
Federal budget cuts have allowed the purchasing power of the National Institute of Health (NIH) to dip 20% in the past decade — resulting in a decline of the funding of qualified NIH research proposals from 30.5% to just 19.1%.
Nearly 20% of U.S. academic researchers are considering conducting research overseas due to lack of funding prospects.
Now is a critical time for researchers to get engaged and educate lawmakers about why medical and biological innovation is mission-critical to the health, well-being, and prosperity of the U.S.
Show your support for medical and biological engineering. Advocate for long-term, consistent funding for our nation’s science agencies. Raise your voice for science today!
Investments in NIH support the work of researchers whose discoveries and innovations save lives and improve the health and well-being of Americans, while investments in NSF support basic research discoveries that serve as the foundation for our nation’s innovation ecosystem. Share these important messages with your Members of Congress about how NIH and NSF are engines for both medical and economic progress. Download, print, and distribute these 1-pagers to Congressional staff during your Capitol Hill visits.
Among AIMBE’s most important roles is the promotion of public policies that foster continued advancement in medical and biological engineering (MBE). We educate public officials, regulators, the media and general public about the positive impact MBE has on virtually every sector of society. AIMBE advocates for public policy solutions that assistant our community at each stage of the innovation ecosystem–from the research lab to the bedside of a patient.